Taylor Morrison Merger Clears HSR Antitrust Hurdle, Nearing Berkshire Hathaway Close
TMHC sits 33% above its 52-week low of $54.15.
Summary
The Hart-Scott-Rodino (HSR) antitrust waiting period for Taylor Morrison's acquisition by Berkshire Hathaway has expired, clearing a key regulatory condition. This follows an 8-K filing minutes earlier and is a procedural step in the $8.5 billion all-cash acquisition announced on May 31st, which valued the company at $72.50 per share. The expiration of the HSR period reduces regulatory risk and moves the deal closer to completion. The merger still requires other regulatory approvals and shareholder adoption, with a special shareholder meeting scheduled for July 22, 2026.
At the time of this announcement, TMHC was trading at $71.88 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $6.6B. The 52-week trading range was $54.15 to $72.50. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.